Download Files:
Products Details
Product Description
– Anagrelide hydrochloride monohydrate is a imidazoquinazoline agent. Anagrelide hydrochloride monohydrate decreases the level of platelets in blood, prevents blood clots formation. Anagrelide hydrochloride monohydrate can be used for research of essential thrombocythaemia (ET) and thrombocythaemia associated with polycythaemia vera (PV)[1].
Web ID
– HY-B0523B
Shipping
– Room temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C10H10Cl3N3O2
References
– [1]Pescatore SL, et al. Anagrelide: a novel agent for the treatment of myeloproliferative disorders. Expert Opin Pharmacother. 2000 Mar;1(3):537-46. |[2]Mahajan R, et al. Phosphodiesterase inhibitors and their role in therapeutics[J]. Journal of Research in Medical Education & Ethics, 2013, 3(2): 115-123.
CAS Number
– 823178-43-4
Molecular Weight
– 310.56
SMILES
– ClC1=C(CN(C2)C3=NC2=O)C(N3)=CC=C1Cl.O.Cl
Clinical Information
– Phase 4
Research Area
– Others
Solubility
– 10 mM in DMSO
Target
– Phosphodiesterase (PDE)
Isoform
– PDE3
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
